ENTX / Entera Bio Ltd. - Net Long/Short Value

Entera Bio Ltd.
US ˙ NasdaqCM ˙ IL0011429839

ENTX / Entera Bio Ltd. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Jpmorgan Chase & Co
Signature Estate & Investment Advisors Llc
Marshall Wace, Llp
Pnc Financial Services Group, Inc.
Northern Trust Corp
XTX Topco Ltd
Schonfeld Strategic Advisors LLC
Bank Of America Corp /de/
Knoll Capital Management, LLC
Citadel Advisors Llc
Renaissance Technologies Llc
Point72 Asset Management, L.P.
Parkman Healthcare Partners LLC
Morgan Stanley
UBS Group AG
SBI Securities Co., Ltd.
Geode Capital Management, Llc
Diadema Partners Lp
HighTower Advisors, LLC
Gem Investment Advisors, LLC
Persistent Asset Partners Ltd
Caitong International Asset Management Co., Ltd
Jane Street Group, Llc
Hrt Financial Lp
Seven Fleet Capital Management LP
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:5DT 1,01 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista